Two week from tomorrow night, on Tuesday November 17, 2015 at 6pm, The Boston Entrepreneurs’ Network (ENET) will hold a meeting on this subject at the group’s Cambridge location: Microsoft Technology Center, One Cambridge Center GENERAL ENTRANCE is on Main Street, Cambridge, across from the Kendall Square Post Office
Discover how Angel and Seed investors approach the problem of making a good investment. Go behind the scenes of the decision making to discover the process our panelist-investors use to choose and to invest in emerging and seed stage companies. Whether you are planning to launch a company or you are planning the next level, a Seed or Angel investor could be the funding source you are looking for. Maybe you’re not even sure what angel investment is? This panel will focus on the nature of angel and seed investments in New England technology based companies, and on how to obtain that initial angel or seed-stage investment in your company. Two of the speakers will be investors in early stage life science companies and the third speaker an investor in other early stage companies. The panelists will also offer candid views and discussion on how to prepare a company for raising angel capital or seed stage investment, the raise itself, and how to work with angel groups or seed investors after getting the investment
Michael Gladstone, Atlas Venture, http://atlasventure-ls.com
Michael Gladstone is a principal at Atlas Venture, where he focuses on new company creation. Michael has been involved in building several Atlas Venture-originated companies, including Spero Therapeutics, Padlock Therapeutics, and Surface Oncology. He has also been closely involved with Atlas’s immuno-oncology investments CoStim Pharmaceuticals (acquired by Novartis) and Unum Therapeutics.
Prior to joining Atlas in 2012, Michael was a senior associate consultant at L.E.K. Consulting, where he focused on business development and corporate strategy for biopharma clients. Previously, Michael worked in the Viral Pathogenesis department of Beth Israel Deaconess Medical Center under Professor Norman Letvin. His research focused on elucidating the role of interleukin-21 in CD8+ T cell memory response to viral antigens.
Michael received an AB in biochemical sciences with highest honors from Harvard College, where he graduated magna cum laude and was awarded the Harvard College Scholarship.
Carl Berke, Partner, Partners HealthCare, http://innovation.partners.org
Carl is a Partner at Partners HealthCare Innovation Fund in Boston, investing in new biomedical technologies emerging from Massachusetts General Hospital and Brigham & Womens Hospital. He is also currently a Founding Director of Mass Medical Angels LLC, a local investment group dedicated to seed stage investment in biomedical innovation. His career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products – he is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a management consultancy focused on innovation and growth strategy. He has served on the boards of Quosa [literature management software], Kasalis [robotics], Annovation [novel anesthetics], Combinent [drug delivery], Sebacia [acne treatment], Infobionic [cardiac monitoring], QPID Health [bioinformatics], LifeImage [diagnostic image sharing], Syntimmune [autoimmune therapy], Argo Cardiovascular and the Sudanese Education Fund [philanthropy]. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the Biomedical Enterprise Program in the Harvard-MIT Division of Health Sciences and Technology.
Catherine Friend White, Managing Director, Golden Seeds.
She is an angel investor and entrepreneur. Her career in investment management spans three decades, most recently as founder and president of FinArc, LLC (www.finarc.com). Her investments include companies in marketing, technology, big data and life sciences. Previously she was on the start-up team for International Heritage where she managed a growth and income mutual fund. White is a director of FinArc Investments, Inc. and the Cutler Center for Investments and Finance. She was a director of BostonFed Bancorp (BFD: American Exchange), Babson College, and other institutions.
She holds the MBA from the F. W. Olin Graduate School of Management at Babson College.
Andrew Snyder, Ph.D., Research Scientist, Broad Institute, Cambridge
Andrew Snyder, Ph.D. is a Research Scientist at the Broad Institute ( https://www.broadinstitute.org ) of MIT and Harvard. In his current role, he focuses on finding novel therapeutics for cardiovascular disease in collaboration with Bayer Healthcare. Prior to working at the Broad, Andy worked at Targanox, Inc, a biotech focused on discovering targeted therapeutics to offset the effects of reactive oxygen species. As part of the initial startup team, Andy was responsible for setting up the biology laboratory, co-developing the proteomics platform and conducting screening assays to identifying targets and inhibitors. Andy completed his post-doctoral training in cancer biology at the Wistar Institute in Philadelphia, PA and was a NRSA NIH/NCI individual award recipient. Andy holds a Ph.D. (Molecular and Cell Biology) and a M.S. degree (Environmental Molecular Biology) from the University of Maryland at Baltimore and a B.S. in microbiology from the University of Maryland at College Park. Andy began volunteering with ENET in 2014.
For more information or to register for the November 17, 2015 ENET meeting, go to http://boston-enet.org/event-2017615
Hopefully, these presentations on Seed and Angel Investing will be helpful to entrepreneurs in small and early stage companies I represent. Hope to see you at ENET’s Cambridge meeting place, at MTC two weeks from tomorrow night at 6pm!
I was a meeting organizer, recruiting Andy as moderator and one of the three speakers. I also organized and moderated another ENET panel on Seed and Angel Financing (for Stratup companies) that was held in Waltham October 2, 2012.
If you would like more information on that October 2012 Seed and Angel Finance panel, I moderated go to http://boston-enet.org/event-545603 At that link you can view slides from all three of our angel and seed investor speakers that included James Geshwiler, Managing Director of Common Angels.
The slides of our October 2012 panel tell how investors approach the problem of making a good investment? The slides also go behind the scenes of the decision making to discover the process our three panelist-investors use to choose and to invest in emerging and seed stage companies.
* * *
I remain active in ENET, a Waltham and Boston /Cambridge based group that aids entrepreneurs, small and early stage companies, and people who invest or work in those companies. I have been on the ENET Board since 2002, and served as Chairman since 2009, just re-elected in May to my fourth 2-year term as ENET Chair. During the period of my leadership, ENET’s annual program has grown from 10 meetings per year to 19 planned for 2015-16: 10 meetings in Waltham, 4 in Boston, 5 in Kendall Square Cambridge, plus our annual cruise of Boston Harbor to end the program year. Each meeting has three or more speakers on a subject of interest to entrepreneurs and company founders, in life science, tech and other areas of New England’s innovation economy.
I am also the moderator or co-organizer for 5 of the 19 ENET meetings as well as the annual cruise of Boston Harbor.
On October 6, 2015, I was meeting organizer and moderator for the ENET meeting on “Innovative Ways to Bootstrap Your Startup Company.” We had three great speakers, a full house in Waltham and great audience questions. To see my write up on the meeting and slides from each of our three ENET speakers, go to http://boston-enet.org/event-2017582
October 6 ENET Speakers:
Joanne Lang, Founder and CEO of AboutOne, www.aboutone.com/about/our-story/
Joanne is the founder and CEO of AboutOne a gamified online organizer that adds filing and reporting capabilities to popular calendar and contacts applications. Using AboutOne products, users can quickly store and manage multi-media memories and household paperwork. Before starting AboutOne in 2010, Joanne was an executive on SAP’s original cloud technology team. She recognized that she had Facebook for friends and LinkedIn for business, but nothing in the middle to help manage her home life. She designed AboutOne based on her experiences as the mother of four. Joanne was named one of Forbes Top Ten Female Entrepreneurs to Watch, and Philadelphia Magazine’s 20 Coolest Start-Ups Oct 2013, received seed funding from Ben Franklin SEP, Series A funding from Golden Seeds and MAG, and was accepted in the Astia and DreamIt portfolios. Joanne shares her insights on both what to do and *not* to do when launching a product and marketing. Her talk will be on “How to Bring Your Product to Market Bootstrapped Style”. For those bootstrapping their companies, hers will be a talk you won’t soon forget. Joanne is a graduate of the University of Manchester Business School, and her passion is her four children, all boys aged 5 to 11. Joanne flew in special from Philadelphia (at her own expense) where she lives to give this presentation and returning that night to be with her family – so ENET was most grateful for her to come and share her insights with us on October 6!
P.S. Joanne’s slides, “”Bring Your Product to Market Bootstrapped Style… and Keep it there” – were also excellent, a great resource, LINK http://boston-enet.org/resources/Documents/Presentation_Lang.pdf
Craig Bloem, Founder and CEO, LogoMix, Inc., www.logomix.com
Craig is an experienced serial entrepreneur focused on marketing and product strategy. He has over 10 years experience in marketing, business development and product management for developing internet businesses. From 2009 to 2011 her was co-Founder and CEO of Performable, a marketing software platform for businesses looking to optimize their marketing, sales and customer service efforts. Performable was acquired by Hubspot for a reported $20 million. Then, in 2011, Craig launched LogoMix to provide small businesses with easy-to-use tools to design and purchase identity products including logos, business cards, pens, polo shirts and other promotional products. Bootstrapped from the get-go, LogoMix has successfully scaled to reach more than 300,000 customers worldwide, and 25 million global users. Craig will relate his best techniques in successfully bootstrapping his companies. Craig is a graduate of Ithaca College, with a BS, Marketing and Management.
Dr. Neil Goldfine, Founder, JENTEK Sensors, Inc., http://www.jenteksensors.com
Dr. Neil Goldfine is the founder, president and chief engineer of JENTEK Sensors, Inc., an Engineering Science company with award winning products for non-destructive testing and structural health monitoring used on a wide variety of industrial, commercial, and government applications. For JENTEK, SBIR grants provided financial resources and infrastructure that have been critical to the company’s growth. The company now employs 27 and the SBIR programs have been credited with allowing the company to grow to critical mass in 10 years rather than 30 years. The program also allowed JENTEK direct access to DoD customers and their defined needs which has also been important to the company’s success. Neil will speak on the SBIR programs and related benefits to bootstrapping companies. Neil has a Ph.D. MIT (1990), M.S. MIT (1985) B.S.E.E. University of Penn, B.S.M.E. University of Penn. (1981), and also has to his credit over 50 patents, numerous publications and technical awards